Firas El Chaer, MD, is an associate professor of medicine who specializes in hematology and oncology. His clinical areas of interest are acute leukemia, chronic leukemia, myelodysplastic syndrome, myeloproliferative disorders, aplastic anemia, clonal hematopoiesis and blood disorders. Dr. El Chaer’s research interests focus on improving the outcomes for acute leukemia in adults by focusing on targeted therapies and overcoming resistance mechanisms, measurable residual disease, and novel therapies for myeloproliferative neoplasm.

Dr. El Chaer attended medical school at the University of Balamand in Beirut, Lebanon, and completed his internal medicine residency at the Icahn School of Medicine at Mount Sinai, Englewood program in New Jersey, where he served as chief resident from 2013-2014. He then completed a fellowship in infectious diseases for immune-compromised cancer patients at the combined program of Baylor College of Medicine and MD Anderson Cancer Center in Houston, Texas. El Chaer pursued a fellowship in hematology and oncology with a focus on blood disorders and also completed a built-in fellowship in stem cell transplantation at the University of Maryland School of Medicine, where he served as a chief fellow from 2018-2019.